Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 26, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Megestrol Acetate, and what generic alternatives are available?

Megestrol Acetate is a drug marketed by Apotex Inc, Wockhardt, Barr, Par Pharm, Twi Pharms Inc, Teva, Usl Pharma, West-ward Pharms Int, and Teva Pharms. and is included in thirteen NDAs.

The generic ingredient in MEGESTROL ACETATE is megestrol acetate. There are eighteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the megestrol acetate profile page.

Summary for Tradename: MEGESTROL ACETATE

Suppliers / Packagers: see list22
Bulk Api Vendors: see list55
Clinical Trials: see list442
Patent Applications: see list6,253
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MEGESTROL ACETATE at DailyMed

Pharmacology for Tradename: MEGESTROL ACETATE

Ingredient-typeProgesterone Congeners
Drug ClassProgestin
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc
megestrol acetate
SUSPENSION;ORAL077404-001Feb 16, 2006DISCNNoNo► Subscribe► Subscribe
Twi Pharms Inc
megestrol acetate
SUSPENSION;ORAL203139-001Aug 27, 2014ABRXNoNo► Subscribe► Subscribe
megestrol acetate
TABLET;ORAL074621-001Nov 30, 1995ABRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
megestrol acetate
TABLET;ORAL074458-002Sep 29, 1995ABRXNoNo► Subscribe► Subscribe
megestrol acetate
TABLET;ORAL074745-001Feb 27, 1998DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus